Fundraising FoxDalCor Pharmaceuticals US
San Mateo, US · Founded 2015 · Delaware LLC
Find your way into DalCor Pharmaceuticals US
Sign up to see every warm intro you have to DalCor Pharmaceuticals US
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DalCor Pharmaceuticals US team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
LP
Louise ProulxExecutive
Board
DM
D. Michael DixonBoard director
RM
Robert McNeilBoard director
DM
Douglas Michael DixonBoard director
LR
Laurence RulleauBoard director
RY
Rody YaredBoard director
GG
Ga?tan GravelBoard director
MS
Mark SmithBoard director
TB
Thomas BirchBoard director
PF
Paul FonteyneBoard director
Reported raises · per SEC filings
Form D private placements$65.8M disclosed across 3 rounds · 2016–2026
▶$7MraisedAug 2026 · 8 investors · PharmaceuticalsRule 506(b)
▶$7MraisedAug 2026 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas Michael DixonDirector
- Paul FonteyneDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Jul 2026
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$3.9MraisedSep 2020 · 4 investors · PharmaceuticalsRule 506(b)
▶$3.9MraisedSep 2020 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Donald BlackDirector
- Paul FonteyneDirector
- D. Michael DixonDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- May 2020
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
▶$55MraisedMay 2017 · 47 investors · PharmaceuticalsRule 506(b)
▶$55MraisedMay 2017 · 47 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Laurence RulleauDirector
- Rody YaredDirector
- Ga?tan GravelDirector
- Mark SmithDirector
- D. Michael DixonExecutive Officer, Director
- Robert McNeilExecutive Officer, Director, Promoter
- Thomas BirchDirector
- Louise ProulxExecutive Officer
- Offering amount
- $110M
- Amount sold
- $55M
- First sale
- Apr 2016
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has DalCor Pharmaceuticals US raised?
- DalCor Pharmaceuticals US has disclosed $65.8M raised across 3 rounds.
- Where is DalCor Pharmaceuticals US headquartered?
- DalCor Pharmaceuticals US is headquartered in San Mateo, US.